The ‘abnormal’ screening serum thyroxine (T4): Analysis of physician response, outcome, cost and health effectiveness
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Journal of Chronic Diseases
- Vol. 34 (5), 175-190
- https://doi.org/10.1016/0021-9681(81)90063-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- DIAGNOSIS OF HYPERTHYROIDISM WHEN SERUM-THYROXINE ALONE IS RAISEDThe Lancet, 1977
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977
- Semi-automated competitive protein binding analysis of serum thyroxine on reusable sephadex columns and its advantages over radioimmunoassayClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- REDUCED ACTIVE THYROID HORMONE LEVELS IN ACUTE ILLNESSThe Lancet, 1976
- Where Now for Saving Lives?Law and Contemporary Problems, 1976
- CONTROVERSY IN THE DETECTION OF DISEASEThe Lancet, 1975
- EFFECT OF SEVERE, CHRONIC ILLNESS ON THYROID FUNCTIONThe Lancet, 1974
- Analysis of a tuberculin testing program using a health status indexSocio-Economic Planning Sciences, 1972
- The "Abnormal" Screening Laboratory ResultsArchives of Internal Medicine, 1972
- A Health-Status Index and its Application to Health-Services OutcomesOperations Research, 1970